mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |